WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark TRIGENESIS was filed as Word mark on 07/20/2020 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1561675 |
| Countries | 
|
| Base trademark |
No. 88811637,
February 26, 2020
|
| Application date | July 20, 2020 |
| Expiration date | July 20, 2030 |
Trademark owner
215 First Street
Cambridge MA 02142
US
Cambridge MA 02142
US
Trademark representatives
250 West 55th Street
New York NY 10019-9710
US
goods and services
05
Pharmaceutical preparations for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders; pharmaceutical preparations based on
morpholino oligomer technology platform; pharmaceutical
preparations that modulate RNA expression; gene therapy
products, namely, gene delivery pharmaceuticals;
pharmaceutical preparations for gene therapy, gene editing,
and genome editing; gene therapy products for the treatment
of neuromuscular diseases and disorders, muscular
dystrophies, central nervous system diseases and disorders,
genetic diseases and disorders; biological preparations for
the treatment of neuromuscular diseases and disorders,
muscular dystrophies, central nervous system diseases and
disorders, genetic diseases and disorders; viruses, viral
vectors and viral constructs for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders; pharmaceutical preparations,
biological preparations and gene therapy products for the
treatment of genetic disorders and diseases
16
Printed materials, namely, brochures, leaflets, reports, and
newsletters on the topics of medicine, medical research,
scientific research, research and development of
pharmaceuticals, biological preparations and gene therapy
products, rare and infectious diseases, neuromuscular
diseases and disorders, muscular dystrophies, central
nervous system diseases and disorders, genetic diseases and
disorders, genetic therapy research, and diagnosis and
treatment of genetic disorders
42
Medical research; medical and scientific research services
all in the field of rare and infectious diseases; medical
and scientific research services all in the field of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, and genetic
diseases and disorders; medical and scientific research
services all in the field of gene therapy, gene editing,
genome editing, viruses, viral vectors, and viral
constructs; providing information in the field of medical
research, scientific research, research and development
relating to pharmaceuticals, biological preparations and
gene therapy products, rare and infectious diseases,
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders, genetic therapy research, and
diagnosis and treatment of genetic disorders via a website
44
Medical information services; providing medical information
via a website; provision of health care services, namely,
providing information to doctors and patients regarding rare
diseases, medicines, health conditions and treatment
options
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 10, 2023 | 2023/3 Gaz | CA | Rejection |
| September 22, 2022 | 2022/38 Gaz | JP | Rejection |
| September 19, 2022 | 2022/38 Gaz | MY | Rejection |
| August 30, 2022 | 2022/35 Gaz | NZ | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| May 23, 2022 | 2022/21 Gaz | TH | Rejection |
| May 9, 2022 | 2022/19 Gaz | MX | Rejection |
| April 4, 2022 | 2022/14 Gaz | KR | Rejection |
| March 29, 2022 | 2022/14 Gaz | CA | Rejection |
| March 28, 2022 | 2022/13 Gaz | IS | Rejection |
| January 27, 2022 | 2022/4 Gaz | TR | Rejection |
| January 13, 2022 | 2022/2 Gaz | CO | Rejection |
| December 10, 2021 | 2021/50 Gaz | BA | Rejection |
| November 1, 2021 | 2021/44 Gaz | KR | Rejection |
| October 21, 2021 | 2021/42 Gaz | JP | Rejection |
| October 19, 2021 | 2021/42 Gaz | CH | Rejection |
| October 14, 2021 | 2021/41 Gaz | NO | Rejection |
| October 4, 2021 | 2022/49 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| August 26, 2021 | 2021/35 Gaz | UA | Rejection |
| August 24, 2021 | 2021/34 Gaz | BR | Rejection |
| July 14, 2021 | 2021/28 Gaz | GB | Rejection |
| June 22, 2021 | 2021/30 Gaz | IN | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| June 2, 2021 | 2021/22 Gaz | DZ | Rejection |
| May 6, 2021 | 2021/18 Gaz | SG | Rejection |
| April 14, 2021 | 2021/15 Gaz | EM | Rejection |
| March 22, 2021 | 2021/13 Gaz | NZ | Rejection |
| March 17, 2021 | 2021/11 Gaz | CN | Rejection |
| March 13, 2021 | 2021/11 Gaz | AU | Rejection |
| February 18, 2021 | 2021/9 Gaz | IL | Rejection |
| February 15, 2021 | 2021/7 Gaz | RU | Rejection |
| December 7, 2020 | 2020/51 Gaz | IN | Rejection |
| July 20, 2020 | 2020/46 Gaz | US | Registration |
ID: 141561675